Pateclizumab (MLTA3698A) is an immunomodulator. It binds to
lymphotoxin alpha
Lymphotoxin-alpha (LT-α) formerly known as tumor necrosis factor-beta (TNF-β) is a protein that in humans is encoded by the ''LTA'' gene. Belonging to the hematopoietic cell line, LT-α exhibits anti-proliferative activity and causes the cellu ...
.
This drug was developed by
Genentech/
Roche
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX ...
.
References
Monoclonal antibodies
{{antineoplastic-drug-stub